Injection Site Irritation Completed Phase 4 Trials for Acetaminophen (DB00316)

IndicationStatusPhase
DBCOND0063115 (Injection Site Irritation)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02524743The Prevention of Pain Associated With Rocuronium InjectionTreatment